Market Value1,642,801,000
Total Holdings75
File Date2019-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Call
CCXI / ChemoCentryx Inc
PHAS / PhaseBio Pharmaceuticals Inc
QTNT / Quotient Ltd
859319303 / Sterling Financial Corp
IFRX / InflaRx N.V.
GTHX / G1 Therapeutics, Inc.
CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019
NKTR / Nektar Therapeutics
ITRM / Iterum Therapeutics plc
NERV / Minerva Neurosciences, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
ALLK / Allakos Inc.
FIXX / Homology Medicines, Inc.
KURA / Kura Oncology, Inc.
BOLD / Boundless Bio, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
TWST / Twist Bioscience Corporation
US62857M1053 / MyoKardia, Inc.
ACRS / Aclaris Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
AVRO / AVROBIO, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
EIGR / Eiger BioPharmaceuticals, Inc.
RARX / Ra Pharmaceuticals, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
NXTC / NextCure, Inc.
SPY / SPDR S&P 500 ETF Put
RETA / Reata Pharmaceuticals Inc - Class A
BHVN / Biohaven Ltd.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
US2103731061 / Constellation Pharmaceuticals Inc
ARNA / Arena Pharmaceuticals Inc
VRTX / Vertex Pharmaceuticals Incorporated
US74257L1089 / Principia Biopharma Inc.
IGMS / IGM Biosciences, Inc.
OTLK / Outlook Therapeutics, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
KZR / Kezar Life Sciences, Inc.
DTIL / Precision BioSciences, Inc.
SRPT / Sarepta Therapeutics, Inc.
XFOR / X4 Pharmaceuticals, Inc.
OTLK / Outlook Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
QURE / uniQure N.V.
QURE / uniQure N.V. Call
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
INSP / Inspire Medical Systems, Inc.
GOSS / Gossamer Bio, Inc.
RUBY / Rubius Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
GNFTF / Genfit S.A.
CRSP / CRISPR Therapeutics AG
ADVM / Adverum Biotechnologies, Inc. Call
ATRA / Atara Biotherapeutics, Inc.
/ Array BioPharma, Inc.
TPTX / Turning Point Therapeutics Inc
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
HARP / Harpoon Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
XLRN / Acceleron Pharma Inc
IMVT / Immunovant, Inc.
MRTX / Mirati Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc. Call
MRTX / Mirati Therapeutics, Inc. Put
BCEL / Atreca, Inc.
AXNX / Axonics, Inc.
BPMC / Blueprint Medicines Corporation
ABEO / Abeona Therapeutics Inc.
NBIX / Neurocrine Biosciences, Inc.
SRRK / Scholar Rock Holding Corporation
YMAB / Y-mAbs Therapeutics, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
BHVN / Biohaven Ltd. Call
APLS / Apellis Pharmaceuticals, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
BBIO / BridgeBio Pharma, Inc.
ANAB / AnaptysBio, Inc.